Drug Profile
Research programme: stem cell-based therapeutics - Aelan Cell Technologies
Alternative Names: Stem cell program - Aelan Cell TechnologiesLatest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator Aelan Cell Technologies
- Class Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for research development in Cancer in USA (Parenteral)